Article
Molecular biology of drug resistance in Mycobacterium tuberculosis.
Current topics in microbiology and immunology - 1 Jan 2013
Smith Tasha, Wolff Kerstin A, Nguyen Liem
Abstract excerpt
Tuberculosis (TB) has become a curable disease, thanks to the discovery of antibiotics. However, it has remained one of the most difficult infections to treat. Most current TB regimens consist of 6-9 months of daily doses of four drugs that are highly toxic to patients. The purpose of these lengthy treatments is to completely eradicate Mycobacterium tuberculosis, notorious for its ability to resist most...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
